Categories

Allergy, Asthma, COPD, Immunophysiology & Immunorehabilitology: Innovative Technologies - 2018 - .PDF

Allergy, Asthma, COPD, Immunophysiology & Immunorehabilitology: Innovative Technologies - 2018 - .PDF
Codice Prodotto: 9788885813045
Disponibilità: In magazzino
Prezzo: 20,00€
(prezzo iva compresa)
Qtà:  
   - O -   

Dear Colleagues and Friends, Ladies and Gentlemen,

This Volume of “Allergy, Asthma, COPD, Immunophysiology & Immunorehabilitology: Innovative Technologies” presents a selection of reports delivered at two Congresses, organized by the World Immunopathology Organization in 2018: XII World Congress on COPD, Asthma & Respiratory Allergy (Dubai, UAE, February 2-5, 2018) and the XI WORLD, ASTHMA, ALLERGY & COPD FORUM held together with the XXV World Congress on Rehabilitation in Medicine and Immunorehabilitation (Barcelona, Spain, April 20-23, 2018).

The lectures and discussions during this Congress will cover every aspect of basic research in the field of asthma, COPD, respiratory allergy, and immunophysiology, and will also bring forth the latest innovations in immunorehabilitology.

The prevalence of asthma and COPD around the world, their severity and mortality rates allow us to consider them as the most socially significant diseases of today and the nearest future. The problem of allergy, asthma, COPD and immunopathology is of global character. Every year the prevalence rate of this pathology is increasing both in adult and children population. The life longevity is diminishing while the quantity of chronic cases and recurrence rate rise sharply. The same is true for the mortality rate of patients with such pathology. That is why, development and implementation of new diagnostics and immunorehabilitation innovative technologies methods is crucial in this situation. They would not only reduce the recurrence rate; these novel innovative methods would also increase the remission duration. It is one of the most vital problems of contemporary medicine. Advances of modern medical science as well as concerted efforts of various specialists – allergologists, immunologists, pediatricians, pulmonologists, dermatologists and other physicians, specialists in cellular and molecular biology, etc. – would contribute a lot to solve these problems.

The world’s leading experts in the field of allergy, asthma and COPD, immunopathology, immunophysiology and immunorehabilitology accepted our invitation and attended this scientific Forum. They represent the World Immunopathology Organization (WIPO), World Allergy Organization (WAO), American College of Allergy, Asthma &Immunology (ACAAI), American Academy of Allergy, Asthma & Immunology (AAAAI), American Thoracic Society (ATS), European Academy of Allergy and Clinical Immunology (EAACI), European Respiratory Society (ERS), Asian Pacific Association of Allergy, Asthma & Clinical Immunology (APAAACI), Asian Pacific Respirology Society (APRS). Some of their reports presented at the Congress are published in this volume.

I sincerely hope that these articles will allow you to obtain new information on the recent advances in the basic knowledge and new innovative technologies in clinical management of allergy, asthma, COPD, immunopathology and immunorehabilitology. This is the main goal of all meetings organized by World Immunopathology Organization (WIPO) and this is the main goal of the materials published in this volume.

 

Professor Revaz SEPIASHVILI, MD, FAAAAI, FACAAI, FACCP
President, World Immunopathology Organization (WIPO)

Scrivi una recensione

Il Tuo Nome:


La Tua Recensione: Nota: Il codice HTML non è tradotto!

Punteggio: Negativo            Positivo

Inserisci il codice nel box di seguito:



Filodiritto Editore è un marchio di inFOROmatica S.r.l. - www.inforomatica.it
Via Castiglione, 81 - 40124 - Bologna, Italia, Tel. 051.98.43.125 - Fax 051.98.43.529
C.F./P.IVA 02575961202, Capitale sociale € 10.000,00 i.v.

Sito realizzato da Carantia Web